It's the first and only drug shown to be effective against the coronavirus in a rigorous trial. But as it stands now, there's only enough remdesivir in the world for about 200,000 patients, according to the drug's maker, Gilead. Who will those patients be? https://t.co/lFy4B6ScQ0